Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis

Abstract

PurposeRheumatoid arthritis (RA) is an inflammatory joint disorder, the progression of which leads to the destruction of cartilage and bone. Chemokines are involved in RA pathogenesis. In this study, we investigated the chemokine signaling pathway associated with CCL2 in peripheral blood (PB) and synovial tissues (ST) of RA patients based on our previous work about chemokine signaling pathway involved in the activation of CCL2 production in collagen-induced arthritis rat ST.Materials and MethodsTotal RNA was isolated from PB leukocytes and synovium of the knee joint in both RA patients and control populations. Real-time polymerase chain reaction was used to determine CCL4, CCR5, c-Jun, c-Fos, and CCL2 expressions. Serum level of CCL2 was assessed by enzyme-linked immunosorbent assay, and the production of CCL2 in ST was analyzed immunohistochemically.ResultsThe expressions of CCL4, CCR5, c-Jun, c-Fos, and CCL2 messenger RNA in RA patients were significantly higher than those in healthy controls, both in ST and on PB leukocyte. Serum CCL2 levels were elevated in RA patients. Histological examination of rheumatoid joints revealed extensive CCL2 expression in RA ST.ConclusionCCL2, CCL4, c-Jun, c-Fos, and CCR5 may play an important role in the recruitment of PB leukocytes into the RA joints. These data provide evidence that the chemokine signaling pathway is involved in CCL2 expression in RA patient tissues, which may contribute to chronic inflammation associated with RA. Targeting this signaling pathway may provide a novel therapeutic avenue in RA.

Evaluation of liposomal carnosine in adjuvant arthritis

“…Data from a study performed in RA patients provide evidence that the chemokine signalling pathway is involved in MCP-1 expression in the patients´ tissues, which may contribute to chronic inflammation associated with RA. Targeting this signalling pathway may provide a novel therapeutic direction in RA (Zhang et al 2015). Liposomal carnosine significantly decreased the plasmatic level of MCP-1 on day 14, while carnosine failed to affect it.…”

Identification of key mRNAs and microRNAs in the pathogenesis and progression of osteoarthritis using microarray analysis

“…Several chemokines have exhibited proinflammatory and angiogenic properties in OA and rheumatoid arthritis (RA) studies (37). Zhang et al (38) demonstrated that the chemokine signaling pathway was involved in CCL2 expression in tissues isolated from patients with RA, which may contribute to the chronic inflammation associated with RA. Cytokine-cytokine receptor interactions have been reported to serve critical roles in OA pathophysiology (39).…”

Effect of lipoic acid on paraoxonase-1 and paraoxonase-3 protein levels, mRNA expression and arylesterase activity in liver hepatoma cells

“…Data from a study performed in RA patients provide evidence that the chemokine signalling pathway is involved in MCP-1 expression in the patients´ tissues, which may contribute to chronic inflammation associated with RA. Targeting this signalling pathway may provide a novel therapeutic direction in RA (Zhang et al 2015). Liposomal carnosine significantly decreased the plasmatic level of MCP-1 on Resistance to Fe 2+ -induced oxidation (τ) in brain homogenate and plasma on day 28.…”